Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing

Cytokine

Volumn 34, Issue 1-2, 2006, Pages 32-38

  Antonelli, Alessandro ^a   Rotondi, Mario ^b   Fallahi, Poupak ^a   Ferrari, Silvia Martina ^a   Paolicchi, Aldo ^c   Romagnani, Paola ^d   Serio, Mario ^d   Ferrannini, Ele ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Ageing; CCL2; CXCL10; Immunity; Thyroid

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNITY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGING; CHEMOKINE CCL2; CHEMOKINES, CXC; CHILD; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; THYROID GLAND;

EID: 33744513348     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.03.012     Document Type: Article

References (43)

1. Martin G.R., Danner D.B., and Holbrook N.J. Aging-causes and defenses. Annu Rev Med 44 (1993) 419-429
2. Miller R.A. The aging immune system: primer and prospectus. Science 273 (1996) 70-74
3. Linton P.J., Haynes L., Tsui L., Zhang X., and Swain S. From naive to effector-alterations with aging. Immunol Rev 160 (1997) 9-18
4. Pulsatelli L., Meliconi R., Mazzetti I., Dolzani P., Meneghetti A., Neri S., et al. Chemokine production by peripheral blood mononuclear cells in elderly subjects. Mech Ageing Dev 121 (2000) 89-100
5. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M.F., Corsi M.P., et al. The immune system in the elderly: I. Specific humoral immunity. Immunol Res 20 (1999) 101-108
6. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M.F., Martorelli V., et al. The immune system in the elderly: II. Specific cellular immunity. Immunol Res 20 (1999) 109-115
7. Shearer G.M. Th1/Th2 changes in aging. Mech Ageing Dev 94 (1997) 1-5
8. Ide K., Hayakawa H., Yagi T., Sato A., Koide Y., Yoshida A., et al. Decreased expression of Th2 type cytokine mRNA contributes to the lack of allergic bronchial inflammation in aged rats. J Immunol 163 (1999) 396-402
9. Li S.P., and Miller R.A. Age-associated decline in IL-4 production by murine T lymphocytes in extended culture. Cell Immunol 151 (1993) 187-195
10. + T cells with ageing. Clin Exp Immunol 120 (2000) 267-273
11. Zlotnik A., and Yoshle O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
12. Baggiolini M. Chemokines and leukocyte traffic. Nature 39 (1998) 565-568
13. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436-445
14. Kemp E.H., Metcalfe R.A., Smith K.A., Woodroofe M.N., Watson P.F., and Weetman A.P. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf) 59 (2003) 207-213
15. Karpus W.J., Lukacs N.W., Kennedy K.J., Smith W.S., Hurst S.D., and Barrett T.A. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158 (1997) 4129-4136
16. Rotondi M., Rosati A., Buonamano A., Lasagni L., Lazzeri E., Pradella F., et al. High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of allograft failure. Am J Transplant 4 (2004) 1466-1474
17. Romagnani P., Rotondi M., Lazzeri E., Lasagni L., Francalanci M., Buonamano A., et al. Expression of IP-10/CXCL10 and Mig/CXCL9 in the thyroid and increased serum levels of IP-10/CXCL10 in the serum of subjects with recent onset Graves' disease. Am J Pathol 161 (2002) 195-206
18. Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S.M., Buonamano A., et al. High levels of circulating CXCL10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 89 (2004) 5496-5499
19. Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S.M., Paolicchi A., et al. Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 152 (2005) 171-177
20. Nicoletti F., Conget I., Di Mauro M., Di Marco M.R., Mazzarino M.C., Bendtzen K., et al. Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45 (2002) 1107-1110
21. Garcià-Lòpez M.A., Sancho D., Sànchez-Madrid F., and Marazuela M. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J Clin Endocrinol Metab 86 (2001) 5008-5016
22. Vanderpump M.P., Tunbridge W.M., French J.M., Appleton D., Bates D., Clark F., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43 (1995) 55-68
23. Inadera H., Egashira K., Takemoto M., Ouchi Y., and Matsushima K. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res 19 (1999) 1179-1182
24. Egashira K. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension 41 (2003) 834-841
25. Kusano K.F., Nakamura K., Kusano H., Nishii N., Banba K., Ikeda T., et al. Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis. Circ J 68 (2004) 671-676
26. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16 (1995) 34-38
27. Weetman A.P. Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol 61 (2004) 405-413
28. Antonelli A., Fallahi P., Nesti C., Pupilli C., Marchetti P., Takasawa S., et al. Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease. Clin Exp Immunol 126 (2001) 426-431
29. Rink L., Cakman I., and Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 102 (1998) 199-209
30. Lisignoli G., Piacentini A., Toneguzzi S., Grassi F., Tschon M., Cristino S., et al. Age-associated changes in functional response to CXCR3 and CXCR5 chemokine receptors in human osteoblasts. Biogerontology 4 (2003) 309-317
31. Franceschi C., Bonafé M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. Inflammaging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908 (2000) 244-254
32. Mysliwska J., Bryl E., Foerster J., and Mysliwski A. Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status. Mech Ageing Dev 100 (1998) 313-328
33. Wei J., Xu H., Davies J.L., and Hemmings G.P. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 51 (1992) 1953-1956
34. Fagiolo U., Cossarizza A., Scala E., Fanales-Belasio E., Ortolani C., Cozzi E., et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23 (1993) 2375-2378
35. Krampera M., Vinante F., Tavecchia L., Morosato L., Chilosi M., Romagnani S., et al. Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration. Clin Exp Immunol 177 (1999) 291-297
36. Gerli R., Monti D., Bistoni O., Mazzone A.M., Peri G., Cossarizza A., et al. Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev 121 (2000) 37-46
37. Daynes R.A., Araneo B.A., Ershler W.B., Maloney C., Li G.Z., and Ryu S.Y. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 150 (1993) 5219-5230
38. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90 (1993) 10193-10197
39. Varagunam M., Finney H., Trevitt R., Sharples E., McCloskey D.J., and Sinnott P.J. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kidney Dis 43 (2004) 502-507
40. Pawlak K., Pawlak D., and Mysliwiec M. Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease. Am J Nephrol 24 (2004) 635-640
41. Romagnani S. The Th1/Th2 paradigm in disease (1997), R.G. Landes Company/Springer-Verlag, New York, NY/Austin
42. Romagnani S. The Th1/Th2 paradigm. Immunol Today 18 (1997) 263-266
43. Antonelli A., Rotondi M., Ferrari S.M., Fallahi P., Romagnani P., Franceschini S.S., et al. Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab 91 2 (2006) 614-620